AUTHORS
Noha Sharafeldin, MD, MSc, PhD, Clare Ubersax2, Landon Martin3, Michelle Martin4, Luciano J. Costa, MD, PhD5, Susan Bal, MD6, Gayathri Ravi, MD7, Kelly Godby, MD8, Caroline Cohen9, Thomas W. Buford10, Kelley Wood11, Mackenzi Pergolotti12, Smith Giri, MD, MS13, Smita Bhatia, MD, MPH14
AFFILIATIONS
1 University of Alabama at Birmingham, Birmingham, Alabama, United States
2 University of Alabama at Birmingham, Birmingham, United States
3 University of Alabama at Birmingham, Birmingham, United States
4 University of Alabama at Birmingham, Birmingham, United States
5 University of Alabama at Birmingham, Birmingham, Alabama, United States
6 University of Alabama at Birmingham, Birmingham, Alabama, United States
7 University of Alabama at Birmingham, Birmingham, Alabama, United States
8 University of Alabama at Birmingham, Birmingham, Alabama, United States
9 University of Alabama at Birmingham, Birmingham, United States
10 University of Alabama at Birmingham, Birmingham, United States
11 Select Medical, Mechanicsburg, United States
12 Select Medical, Mechanicsburg, United States
13 University of Alabama at Birmingham, Birmingham, United States
14 University of Alabama at Birmingham, Birmingham, United States
ABSTRACT
Background: Over half of older adults with multiple myeloma (MM) receiving autologous stem cell transplantation (ASCT) experience clinically significant decline in physical function post-transplant, which poses limits to patients’ functional independence. Despite well-known benefits of prehabilitation on preservation of function in other clinical scenarios (e.g. surgery) it has not been tested in older patients undergoing transplantation. Furthermore, patient access to hospital-based rehabilitation programs is an important barrier that can potentially be mitigated via telehealth. We conducted a randomized controlled trial at a single academic center testing the feasibility and acceptability of an 8-week supervised telehealth enabled prehabilitation program vs usual care to preserve physical performance in older adults (≥60y) with MM prior to receiving ASCT.
Methods: Patients randomized to tele-prehabilitation arm attended supervised exercise sessions led by licensed physical therapists twice a week (total 16 sessions). Each therapy session comprised patient education, preferred aerobic activity, progressive strength training focusing on core and major muscle groups, and adaptive resistance training using resistance bands. Feasibility outcomes included recruitment, retention, and adherence to intervention rates. Objective physical performance was assessed using 6 Minute Walk Test (6MWT) to assess aerobic capacity and endurance and handgrip dynamometer capturing the hand grip strength. Subjective measures of physical functioning included Activities of Daily Living (ADL), instrumental ADL (IADL) and Life Space Questionnaire (LSQ). Clinically meaningful change in physical function was defined as: a) 20-30 meters in 6MWT, b) 3kg in hand-grip strength, c) ≥1 point change in ADL or IADL, and d) ≥5 points on LSQ. Acceptability was measured using the Theoretical Framework of Acceptability (TFA) questionnaire. Within-arm change scores (post-intervention minus baseline) were calculated for subjective and objective scores. Between-arm differences in change scores were assessed using independent-samples t-tests, and effect sizes were estimated using Hedge's g.
Results: Feasibility: Of the 57 eligible patients approached, 36 (63%) consented and were randomized (18 to intervention arm; 18 to control arm). Main reason for refusal (86%) was lack of interest in research. Post-randomization 7 patients withdrew (4 intervention, 2 control). Median age at enrollment was 68.9y (range: 60.5-77.9), 64.7% were males, 67.7% non-Hispanic White, and 23.5% non-Hispanic Black, 70.6% had college or more education, 55.9% are retired, 76.5% were married, and 82.4% did not live alone. There were no significant differences between arms. Adherence on active arm: Active participants completed a median of 14 sessions; 85.7% completed ≥8 sessions. Preliminary Efficacy: the intervention led to clinically significant improvement in the primary outcome of 6MWT (mean difference of 40.5m improvement pre-post intervention vs -41.5m decline in control arm, g=1.47 (95%CI: 0.22-2.66), p=0.02). Change in hand grip strength was favorable for the intervention arm (mean difference of 1.5kg improvement pre-post intervention vs -2.9kg decline in control arm, g=0.21 (-0.64-1.06), p=0.47). ADL and IADL improved by 1 and 1.5 points in the intervention arm vs 0.13 and 0.33 points in the control arm, respectively. LSQ scores improved by 30.5 points in the intervention arm vs -4.43 points decline in the control arm, g=0.92 (95%CI: 0.15-1.67), p=0.02. Acceptability: the intervention was highly acceptable across TFA domains, 84.6% reported global acceptability and perceived effectiveness, 100% demonstrated positive affective attitudes and intervention coherence. Perceived burden was low (23.1%), and self-efficacy was high (76.9%).
Conclusions: A home-based tele-prehabilitation exercise program was feasible and acceptable in older adults with MM undergoing ASCT. The program demonstrated clinically meaningful pre-treatment functional optimization. Findings lay a solid foundation for a future definitive trial to assess the benefit of tele-prehabilitation programs.
DISCLOSURES
Noha Sharafeldin, MD, MSc, PhD: Janssen - Research Funding